News & Updates

A polysocial score (PSS) for coronary heart disease (CHD) can predict incident CHD, suggests a study. Combining PSSCHD with a polygenic risk score (PRS) results in improvements in the performance of clinical risk calculators.

On October 25, 2024, gastroenterologists and hepatologists gathered at the Globe Auditorium, BGC braving the raging typhoon to listen to top experts talk about updates in clinical practice in managing liver disease. This was the second installment of a 2-day lecture series sponsored by Opella Healthcare Philippines.

The Golden Liver Health Forum, convened on October 24, 2024, at the Globe Auditorium in BGC, presented evolving multi-disciplinary strategies in managing Metabolic Associated Fatty Liver Disease (MAFLD). Through insightful discussions from top experts in endocrinology, cardiology, and hepatology—Bien Matawaran, MD, Louella Santos, MD, and Stephen Wong, MD, chaired by Prof Jose D. Sollano Jr., MD, the forum provided clinicians with valuable, patient-centered strategies that enhance risk assessment and management for these intertwined health concerns.

The evidence supporting an upfront daratumumab-containing regimen as the SoC for AL amyloidosis is reaffirmed by the significant OS benefit demonstrated in the final analysis of ANDROMEDA

People exposed to nitrogen (NO2) in the long term are at risk of a range of diseases, including cardiovascular, respiratory, and musculoskeletal diseases, according to a study conducted in China.

Factors such as male sex, older age, and prior X-ray examination are linked to an increased risk of major adverse cardiovascular events (MACE) and malignancies in patients with rheumatoid arthritis, according to a study from Japan.